Fennec Pharmaceuticals Inc (FRX : TSX)
Common Stock
$16.51
CAD
-1.12 (-6.35%)
Last updated: 2026-08-12
Get FRX alerts:
FRX
Fennec Pharmaceuticals Inc
WealthAwesomePerformance
1 Day
-6.35%
1 Week
+10.95%
1 Month
+11.63%
YTD
+58.60%
Key Statistics
Market Cap
$617.65M
52W High
$17.64
52W Low
$7.59
P/E Ratio
-
50 Day MA
$14.13
200 Day MA
$11.51
Beta
1.07
Dividend Yield
-
Advertisement
Technical Indicators
Price vs 50-Day SMA
Price vs 200-Day SMA
Recent Price History
| Date | Open | High | Low | Close | Adj Close | Volume |
|---|---|---|---|---|---|---|
| 8/12/2026 | $16.95 | $17.01 | $16.51 | $16.51 | $16.51 | 804 |
| 8/11/2026 | $16.74 | $17.64 | $16.54 | $17.63 | $17.63 | 2,365 |
| 8/10/2026 | $15.35 | $15.35 | $15.20 | $15.28 | $15.28 | 2,200 |
| 8/7/2026 | $15.60 | $16.10 | $15.60 | $16.02 | $16.02 | 1,929 |
| 8/6/2026 | $15.00 | $15.00 | $15.00 | $15.00 | $15.00 | 138 |
| 8/5/2026 | $14.88 | $14.88 | $14.88 | $14.88 | $14.88 | 101 |
| 7/31/2026 | $13.85 | $13.85 | $13.85 | $13.85 | $13.85 | 200 |
| 7/30/2026 | $13.85 | $13.85 | $13.85 | $13.85 | $13.85 | 125 |
| 7/29/2026 | $13.95 | $13.95 | $13.95 | $13.95 | $13.95 | 0 |
| 7/28/2026 | $13.85 | $14.40 | $13.85 | $13.95 | $13.95 | 1,949 |
Analyst Price Targets
Based on analyst covering FRX
Wall Street analysts forecast FRX stock price to rise 466.7% over the next 12 months.
Consensus
BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$93.57
+466.7% Upside
Current Price
C$16.51
Last close
Analyst ratings and price targets are updated periodically. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on FRX's historical volatility
30-Day Vol
63.0%
Annualized
90-Day Vol
80.0%
Annualized
Trend (90d)
+50.0%
Annualized drift
90d Mean
C$19.74
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$17.52 | C$14.10 – C$21.78 |
| 60 trading days | C$18.60 | C$13.67 – C$25.29 |
| 90 trading days | C$19.74 | C$13.54 – C$28.77 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
About Fennec Pharmaceuticals Inc
Fennec Pharmaceuticals Inc. operates as a commercial stage biopharmaceutical company in the United States. The company's product candidate includes PEDMARK, a formulation of sodium thiosulfate for the prevention of cisplatin-induced ototoxicity pediatric patients. It sells its products through regional pediatric oncology specialists and medical science liaisons. Fennec Pharmaceuticals Inc. has collaboration with Tampa General Hospital Foundation, Inc. for evaluation of clinical utility of sodium thiosulfate injection in reducing the risk of ototoxicity in adolescent, young adult, and adult cancer patients receiving cisplatin-based treatment; and Norgine Pharma UK Limited. The company was formerly known as Adherex Technologies Inc. and changed its name to Fennec Pharmaceuticals Inc. in September 2014. Fennec Pharmaceuticals Inc. was incorporated in 1996 and is based in Research Triangle Park, North Carolina.
Financials
- Revenue (TTM)
- $51.00M
- EBITDA
- $-5.49M
- Profit Margin
- -16.42%
- ROE (TTM)
- -52.68%
- EPS (Diluted)
- -0.40
- Book Value
- 1.52
Classification
- Sector
- Health Care
- Industry
- Biotechnology
- Group
- Pharmaceuticals, Biotechnology & Life Sciences
7 stocks to buy and hold forever
Blue-chip dividend stocks for long-term wealth building.
Get the FREE ReportExplore More
Advertisement
Common Questions About FRX
Market movers
Recent TSX movers
Top 1-day gainers — updated from our Canadian movers feed.
FRX.TO news timeline
15 articles covering FRX.TO, most recent first
LatestWhy Fennec Pharmaceuticals Inc stock surged yesterday
August 2026
- Fennec Pharmaceuticals Inc FRX Earnings Beat Estimates by 248.5%
- Why Fennec Pharmaceuticals Inc stock is skyrocketing today
- Why Fennec Pharmaceuticals Inc stock surged yesterday
- Will Fennec Pharmaceuticals Inc (FRX) Beat Estimates Again in Its Next Earnings Report?
- Why Fennec Pharmaceuticals Inc stock surged yesterday
- What's Going On With Fennec Pharmaceuticals Inc Stock Thursday?
- Why Fennec Pharmaceuticals Inc stock is skyrocketing today
July 2026
- What's Going On With Fennec Pharmaceuticals Inc Stock Thursday?
- Why Fennec Pharmaceuticals Inc stock is plummeting today
- What's Going On With Fennec Pharmaceuticals Inc Stock Tuesday?
- Why Fennec Pharmaceuticals Inc stock is sliding today
- Why Fennec Pharmaceuticals Inc stock is sliding today
- What's Going On With Fennec Pharmaceuticals Inc Stock Wednesday?
- Why Fennec Pharmaceuticals Inc stock is rising today